Download PDF
Semin Liver Dis 2001; 21(1): 003-016
DOI: 10.1055/s-2001-12925
Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Nonalcoholic Steatohepatitis: Definition and Pathology

Elizabeth M. Brunt
  • Department of Pathology, Saint Louis University School of Medicine, St. Louis, Missouri
Further Information

Publication History

Publication Date:
31 December 2001 (online)

    Permissions and Reprints

ABSTRACT

Nonalcoholic steatohepatitis (NASH) is a significant form of chronic liver disease in adults and children. The natural history of NASH ranges from indolent to end-stage liver disease. Current studies are focusing on identification of histologic and/or clinical markers of progression. NASH may be an underlying cause of cryptogenic cirrhosis, and the lesions of NASH may recur in allograft livers. An expanding array of clinical conditions and pathogenetic mechanisms have been identified, but many cases remain ``idiopathic''; lack of significant alcohol use is, by definition, common to all cases. Neither clinical evaluation nor laboratory values can ensure either the diagnosis or the exclusion of NASH, and liver biopsy interpretation continues to be considered the ``gold standard'' for diagnosis. The lesions in NASH are similar but not identical to those of alcoholic steatohepatitis; exact, specific histologic criteria for the diagnosis are currently under discussion. The lesions most commonly accepted for NASH include steatosis, hepatocyte ballooning degeneration, mild diffuse lobular mixed acute and chronic inflammation, and perivenular, perisinusoidal collagen deposition. Zone 3 accentuation may be detected. Mallory's hyaline, vacuolated nuclei in periportal hepatocytes, lobular lipogranulomas, and PAS-diastase-resistant Kupffer cells are common. In biopsy specimens from children, portal inflammation may be more prominent than in adults. Progression of fibrosis may result in bridging septa and cirrhosis. The lesions of steatohepatitis may be noted concurrently with other forms of chronic liver disease. A histological ``grading and staging'' system has been developed to reflect the unique features of steatohepatitis, gradations of severity and fibrosis, and to promote uniform reporting of the histopathology.

KEYWORD

NASH - histopathologic lesions

REFERENCES

  • 1 Teli M R, James O FW, Burt A D. The natural history of nonalcoholic fatty liver: a follow-up study.  Hepatology . 1995;  22 1714-1719
    CrossrefPubMedGoogle Scholar
  • 2 Day C P, James O FW. Hepatic steatosis: innocent bystander or guilty party?.  Hepatology . 1998;  27 1463-1466
    CrossrefPubMedGoogle Scholar
  • 3 Burt A D, Mutton A, Day C. Diagnosis and interpretation of steatosis and steatohepatitis.  Semin Diagn Pathol . 1998;  15 246-258
    PubMedGoogle Scholar
  • 4 Gerber M A, Krawczynski K, Alter M J. Histopathology of community acquired chronic hepatitis C.  Mod Pathol . 1992;  5 483-486
    PubMedGoogle Scholar
  • 5 Scheuer P J, Ashrafzadeh P, Sherlock S. The pathology of hepatitis C.  Hepatology . 1992;  15 567-571
    PubMedGoogle Scholar
  • 6 Lefkowitch J H, Schiff E R, Davis, G L. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B.  Gastroenterology . 1993;  104 595-603
    PubMedGoogle Scholar
  • 7 Matteoni C A, Younossi Z M, Gramlich T. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.  Gastroenterology . 1999;  116 1413-1419
    CrossrefPubMedGoogle Scholar
  • 8 Wanless I R, Lentz J S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.  Hepatology . 1990;  12 1106-1110
    CrossrefPubMedGoogle Scholar
  • 9 Day C P, James O FW. Steatohepatitis: a tale of two ``hits''?.  Gastroenterology . 1998;  114 842-845
    CrossrefPubMedGoogle Scholar
  • 10 Chavin K, Yang S Q, Lin H Z. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion.  J Biol Chem . 1999;  274 5692-5700
    PubMedGoogle Scholar
  • 11 Deschamps D, De Beco V, Fisch C. Inhibition by perhexiline of oxidative phosphorylation and the β-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions.  Hepatology . 1994;  19 948-961
    CrossrefPubMedGoogle Scholar
  • 12 Berson A, De Beco V, Letteron P. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes.  Gastroenterology . 1998;  114 764-774
    PubMedGoogle Scholar
  • 13 Caldwell S H, Swerdlow R H, Khan E M. Mitochondrial abnormalities in non-alcoholic steatohepatitis.  J Hepatol . 1999;  31 430-434
    CrossrefPubMedGoogle Scholar
  • 14 James O FW, Day C P. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance.  J Hepatol . 1998;  29 495-501
    PubMedGoogle Scholar
  • 15 Diehl A M. Nonalcoholic steatohepatitis.  Semin Liver Dis . 1999;  19 221-229
    PubMedGoogle Scholar
  • 16 Rashid M, Roberts E A. Nonalcoholic steatohepatitis in children.  J Pediatr Gastroenterol Nutr . 2000;  30 48-53
    CrossrefPubMedGoogle Scholar
  • 17 Powell E E, Cooksley W GE, Hanson R. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.  Hepatology . 1990;  11 74-80
    CrossrefPubMedGoogle Scholar
  • 18 Abdelmalek M, Ludwig J, Lindor K D. Two cases from the spectrum of nonalcoholic steatohepatitis.  J Clin Gastroenterol . 1995;  20 127-130
    PubMedGoogle Scholar
  • 19 Neuschwander-Tetri B A, Bacon B R. Nonalcoholic steatohepatitis.  Med Clin North Am . 1996;  80 1147-1166
    PubMedGoogle Scholar
  • 20 Sheth S G, Gordon F D, Chopra S. Nonalcoholic steatohepatitis.  Ann Intern Med . 1997;  126 137-145
    PubMedGoogle Scholar
  • 21 Lonardo A. Fatty liver and nonalcoholic steatohepatitis. Where do we stand and where are we going?.  Dig Dis . 1999;  17 80-89
    CrossrefPubMedGoogle Scholar
  • 22 Ludwig J, McGill D B, Lindor K D. Metabolic liver disease.  Review: nonalcoholic steatohepatitis. J Gastroenterol Hepatol . 1997;  12 398-403
    CrossrefPubMedGoogle Scholar
  • 23 Angulo P, Keach J C, Batts K P. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.  Hepatology . 1999;  30 1356-1362
    CrossrefPubMedGoogle Scholar
  • 24 Hay J E, Czaja A J, Rakela J. The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients.  Hepatology . 1989;  9 193-197
    PubMedGoogle Scholar
  • 25 Byron D, Miruk G Y. Profile of an urban hospital-based practice.  Hepatology . 1996;  24 813-815
    CrossrefPubMedGoogle Scholar
  • 26 James O, Day C. Non-alcoholic steatohepatitis: another disease of affluence. Commentary.  Lancet . 1999;  353 1634-1636
    CrossrefPubMedGoogle Scholar
  • 27 Daniel S, Ben-Menachem T, Vasudevan G. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients.  Am J Gastroenterol . 1999;  94 3010-3014
    CrossrefPubMedGoogle Scholar
  • 28 Baldridge A D, Perez-Atayde A R, Graeme-Cook F. Idiopathic steatohepatitis in childhood: a multicenter retrospective study.  J Pediatr . 1995;  127 700-704
    PubMedGoogle Scholar
  • 29 Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients.  Am J Med . 1979;  67 811-816
    CrossrefPubMedGoogle Scholar
  • 30 Itoh S, Yougel T, Kawagoe K. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis.  Am J Gastroenterol . 1987;  82 650-654
    PubMedGoogle Scholar
  • 31 Diehl A M, Goodman Z, Ishak K G. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury.  Gastroenterology . 1988;  95 1056-1062
    PubMedGoogle Scholar
  • 32 Lee R G. Nonalcoholic steatohepatitis: a study of 49 patients.  Hum Pathol . 1989;  20 594-598
    CrossrefPubMedGoogle Scholar
  • 33 Bacon B R, Farahvash M J, Janney C G. Nonalcoholic steatohepatitis: an expanded clinical entity.  Gastroenterology . 1994;  107 1103-1109
    PubMedGoogle Scholar
  • 34 Ratziu V, Giral P, Charlotte F. Liver fibrosis in overweight patients.  Gastroenterology . 2000;  118 1117-1123
    CrossrefPubMedGoogle Scholar
  • 35 French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsies in patients with chronic hepatitis C.  Hepatology . 1994;  20 15-20
    CrossrefPubMedGoogle Scholar
  • 36 Caldwell S H, Oelsner D H, Iezzonie J C. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.  Hepatology . 1999;  29 664-669
    CrossrefPubMedGoogle Scholar
  • 37 Kim W R, Peterucha J J, Porayko M K. Recurrence of non-alcoholic steatohepatitis following liver transplantation.  Transplantation . 1996;  62 1802-1805
    PubMedGoogle Scholar
  • 38 Carson K, Washington M K, Treem W R. Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient.  Liver Transplant Surg . 1997;  3 174-176
    CrossrefPubMedGoogle Scholar
  • 39 Molloy R M, Komorowski R, Varma R R. Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation.  Liver Transplant Surg . 1997;  3 177-178
    CrossrefPubMedGoogle Scholar
  • 40 Cotrim H P, Adrade Z A, Parana R. Nonalcoholic steatohepatitis. A toxic liver disease in industrial workers.  Liver . 1999;  19 299-304
    PubMedGoogle Scholar
  • 41 Blendis L, Oren R, Halpern Z. NASH: can we iron out the pathogenesis?.  <~>Selected summary. Gastroenterology . 2000;  118 981-983
    PubMedGoogle Scholar
  • 42 Bonkovsky H L, Jawaid Q, Tortorelli K. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.  J Hepatol . 1999;  31 421-429
    CrossrefPubMedGoogle Scholar
  • 43 George D K, Goldwurm S, Macdonald G A. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.  Gastroenterology . 1998;  114 311-318
    CrossrefPubMedGoogle Scholar
  • 44 Younossi A M, Gramlich T, Bacon B R. Hepatic iron and nonalcoholic fatty liver disease.  Hepatology . 1999;  30 847-850
    CrossrefPubMedGoogle Scholar
  • 45 Mendler M-H, Turlin B, Moriand R. Insulin resistance- associated hepatic iron overload.  Gastroenterology . 1999;  117 1155-1163
    CrossrefPubMedGoogle Scholar
  • 46 Macdonald G A, Powell L W. More clues to the relationship between hepatic iron and steatosis: an association with insulin resistance?.  <~>Editorial. Gastroenterology . 1999;  117 1241-1244
    PubMedGoogle Scholar
  • 47 McCoullough A J, Falck-Ytter Y. Body composition and hepatic steatosis as precursors for fibrosis in liver disease.  Hepatology . 1999;  29 1328-1329
    CrossrefPubMedGoogle Scholar
  • 48 Ludwig J, Viggiano T R, McGill D B. Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease.  Mayo Clin Proc . 1980;  55 434-438
    PubMedGoogle Scholar
  • 49 Brunt E M, Neuschwander-Tetri B A, Di Bisceglie M A. Can steatohepatitis coexist with other forms of chronic liver disease?.  Mod Pathol . 2000;  13 1061A
    PubMedGoogle Scholar
  • 50 Peters R L, Gay T, Reynolds T B. Post-jejunoileal bypass hepatic disease. Its similarity to alcoholic liver disease.  Am J Clin Pathol . 1975;  63 318-331
    PubMedGoogle Scholar
  • 51 Marubbio A T, Buchwald H, Schwartz M Z. Hepatic lesions of central pericellular fibrosis in morbid obesity and after jejunoileal bypass.  Am J Clin Pathol . 1976;  66 684-691
    PubMedGoogle Scholar
  • 52 Hamilton D L, Vest F K, Brown B S. Liver injury with alcoholic like hyaline after gastroplasty for morbid obesity.  Gastroenterology . 1983;  85 722-726
    PubMedGoogle Scholar
  • 53 Vyberg M, Ravn V, Andersen B. Pattern of progression in liver injury following jejunoileal bypass for morbid obesity.  Liver . 1987;  7 271-276
    PubMedGoogle Scholar
  • 54 Nagore N, Scheuer P J. The pathology of diabetic hepatitis.  J Pathol . 1988;  156 155-160
    PubMedGoogle Scholar
  • 55 Wanless I R, Bargman J M, Oreopoulos D G. Subcapsular steatonecrosis in response to peritoneal insulin delivery: a clue to the pathogenesis of steatonecrosis in obesity.  Mod Pathol . 1989;  2 69-74
    PubMedGoogle Scholar
  • 56 Younossi Z M, Gramlich T, Chang Y. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.  Mod Pathol . 1998;  11 560-565
    PubMedGoogle Scholar
  • 57 Lee R G. Nonalcoholic steatohepatitis: tightening the morphologic screws on a hepatic ramber.  Hepatology . 1995;  21 1742-1743
    CrossrefPubMedGoogle Scholar
  • 58 Brunt E M, Janney C G, Di Bisceglie M A. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.  Am J Gastroenterol . 1999;  94 2467-2474
    CrossrefPubMedGoogle Scholar
  • 59 Teli M R, Day C P, Burt A D. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver.  Lancet . 1995;  346 987-990
    CrossrefPubMedGoogle Scholar
  • 60 Pinto H C, Baptista A, Camilo M E. Nonalcoholic steatohepatitis: clinicopathologic comparison with alcoholic hepatitis in ambulatory and hospitalized patients.  Dig Dis Sci . 1996;  41 172-179
    PubMedGoogle Scholar
  • 61 Andersen T, Gluud C, Franzmann M-B. Hepatic effects of dietary weight loss in morbidly obese subjects.  J Hepatol . 1991;  12 224-229
    CrossrefPubMedGoogle Scholar
  • 62 Lee R G. Diagnostic Liver Pathology.  St. Louis: Mosby, 1994: 167-194
    Google Scholar
  • 63 Thung S N, Gerber M A. Differential Diagnosis in Pathology: Liver Disorders.  New York: Igaku-Shoin, 1995: 24
    Google Scholar
  • 64 Hall de la P. Alcoholic liver disease. In: MacSween RNM, Anthony PP, Scheuer PJ, et al. eds. Pathology of the Liver. London: Churchill Livingstone 1994: 317-349
    Google Scholar
  • 65 Scheuer P J. Classification of chronic viral hepatitis: a need for reassessment.  J Hepatol . 1991;  13 372-374
    CrossrefPubMedGoogle Scholar
  • 66 MacSween R NM, Burt A D. Histologic spectrum of alcoholic liver disease.  Semin Liver Dis . 1986;  6 221-232
    Article in Thieme ConnectPubMedGoogle Scholar
  • 67 Goodman Z D, Ishak K G. Occlusive venous lesions in alcoholic liver disease. A study of 200 cases.  Gastroenterology . 1982;  83 786-796
    PubMedGoogle Scholar
  • 68 Washington K, Wright K, Hunter E. Hepatic stellate cell activation in non-alcoholic steatohepatitis.  Mod Pathol . 1999;  12 169A
    PubMedGoogle Scholar
  • 69 Brunt E M, Fazel A, Brown K E. Lack of zonal association between α-smooth muscle actin (SMA), CD 34 and fibrosis in a variety of liver diseases.  Hepatology . 1999;  30 554A
    PubMedGoogle Scholar
  • 70 Friedman S L. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies.  N Engl J Med . 1993;  328 1828-1835
    CrossrefPubMedGoogle Scholar
  • 71 Ramm G A, Crawford D HG, Powell L W. Hepatic stellate cell activation in genetic hemochromatosis.  J Hepatol . 1997;  26 584-592
    CrossrefPubMedGoogle Scholar
  • 72 Cordes B G, Brown K E, Brunt E M. Zonal localization of alpha-smooth muscle actin and CD34 immunoreactivity in chronic cholestatic liver disease.  Mod Pathol . 2000;  13 182A
    PubMedGoogle Scholar
  • 73 Brunt E M. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell Histology Activity Index and beyond.  Hepatology . 2000;  31 241-246
    CrossrefPubMedGoogle Scholar
  • 74 Knodell R G, Ishak K G, Black W C. Formulation and application of numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.  Hepatology . 1981;  1 431-435
    CrossrefPubMedGoogle Scholar
  • 75 Ludwig J. The nomenclature of chronic active hepatitis: an obituary.  Gastroenterology . 1993;  105 274-278
    PubMedGoogle Scholar
  • 76 Desmet V J, Gerber M, Hoofnagle J H. Classification of chronic hepatitis: diagnosis, grading and staging.  Hepatology . 1994;  19 1513-1520
    CrossrefPubMedGoogle Scholar
  • 77 Ishak K G, Baptista A, Bianchi L. Histological grading and staging of chronic hepatitis.  J Hepatol . 1995;  22 696-699
    CrossrefPubMedGoogle Scholar
  • 78 Goldin R D, Goldin J G, Burt A D. Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis.  J Hepatol . 1996;  25 649-654
    CrossrefPubMedGoogle Scholar
  • 79 Westin J, Lagging L M, Wejstal R. Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection.  Liver . 1999;  19 183-187
    CrossrefPubMedGoogle Scholar
  • 80 Scheuer P. Primary biliary cirrhosis.  Proc R Soc Med . 1967;  60 1257-1260
    PubMedGoogle Scholar
  • 81 Ludwig J, Dickson E R, McDonald G S. Staging of chronic non-suppurative destructive cholangitis (syndrome of primary biliary cirrhosis).  Virchows Arch Pathol Anat . 1978;  379 103-112
    PubMedGoogle Scholar
  • 82 Ludwig J, LaRusso N F, Weisner R H. Primary Sclerosing Cholangitis. In: Peters RC, Craig JR (eds. Contemporary Issues in Surgical Pathology, Vol 8. Liver Pathology. New York: Churchill Livingstone 1986: 193-213
    Google Scholar
  • 83 Searle J, Kerr J RF, Halliday J W. Iron storage disease. In: MacSween RNM, Anthony PP, Scheuer PJ, et al. Pathology of the Liver London: Churchill Livingstone 1994: 224
    Google Scholar
  • 84 Ishak K G. Chronic hepatitis: morphology and nomenclature.  Mod Pathol . 1994;  7 690-713
    PubMedGoogle Scholar
  • 85 McFarlane I G. Hepatitis C and alcoholic liver disease.  Am J Gastroenterol . 1993;  88 982-988
    PubMedGoogle Scholar
  • 86 Nalpas B, Bhrechot C, Berthelot P. Hepatitis B virus and alcoholism. A puzzling association.  Hepatology . 1988;  18 11-14
    PubMedGoogle Scholar
  • 87 George D K, Powell L W, Losowsky M S. The haemochromatosis gene: a co-factor for chronic liver disease?.  J Gastroenterol Hepatol . 1999;  14 745-749
    PubMedGoogle Scholar
  • 88 Fong T-S, Di Bisceglie M A, Waggoner J G. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.  Hepatology . 1991;  14 64-67
    PubMedGoogle Scholar
  • 89 DeCastro M, Sanchez J, Herrera J F. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda.  Hepatology . 1993;  17 551-557
    PubMedGoogle Scholar
  • 90 Propst T, Propst A, Dietze O. High prevalence of viral infection in adults with homozygous and heterozygous alpha-1-antitrypsin deficiency and chronic liver disease.  Ann Intern Med . 1992;  17 641-645
    PubMedGoogle Scholar
  • 91 Brunt E M, Tavill A S, Bacon B R. A 49-year-old man with alpha-1-antitrypsin deficiency and abnormal iron studies.  Semin Liver Dis . 1996;  16 97-101
    PubMedGoogle Scholar
  • 92 Mason A L, Lau J YN, Hoang N. Association of diabetes mellitus and chronic hepatitis C virus infection.  Hepatology . 1999;  29 328-333
    CrossrefPubMedGoogle Scholar
  • 93 Caronia S, Taylor K, Pagliaro L. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection.  Hepatology . 1999;  30 1059-1063
    CrossrefPubMedGoogle Scholar
  • 94 Hourigan L F, Macdonald G A, Purdie D. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis.  Hepatology . 1999;  29 1215-1219
    CrossrefPubMedGoogle Scholar
  • 95 Moryia K, Yotsuyanagi H, Shintani Y. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.  J Gen Virol . 1997;  78 1527-1531
    PubMedGoogle Scholar
  • 96 Rogers D W, Lee C H, Pound D C. Hepatitis C virus does not cause steatohepatitis.  Dig Dis Sci . 1992;  37 1644-1649
    PubMedGoogle Scholar
      >